Garon, Edward B. Ciuleanu, Tudor-Eliade Arrieta, Oscar and Prabhash, Kumar Syrigos, Konstantinos N. Goksel, Tuncay and Park, Keunchil Gorbunova, Vera Dario Kowalyszyn, Ruben and Pikiel, Joanna Czyzewicz, Grzegorz Orlov, Sergey V. and Lewanski, Conrad R. Thomas, Michael Bidoli, Paolo Dakhil, Shaker Gans, Steven Kim, Joo-Hang Grigorescu, Alexandru and Karaseva, Nina Reck, Martin Cappuzzo, Federico Alexandris, Ekaterine Sashegyi, Andreas Yurasov, Sergey Perol, Maurice, Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line
treatment of stage IV non-small-cell lung cancer after disease
progression on platinum-based therapy (REVEL): a multicentre,
double-blind, randomised phase 3 trial, The Lancet Neurology, (384), 665-673, 2014, EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC,